NovImmune novimmune.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

NovImmune is a biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.

NovImmune is a biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.

Company (Alive / Active)

Phone: +41 22 839 71 41

Fax:

14 Chemin des Aulx
Plan-Les-Ouates
Geneva, CH-1228
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NovImmune $256.8M May 11, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NovImmune Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods for the generation of multispecific and multivalent antibodies Oct 10, 2013 Mar 27, 2018 Patent
Anti-cd3 antibodies and methods of use thereof Oct 08, 2013 Dec 26, 2017 Patent
Methods for the generation of multispecific and multivalent antibodies Aug 16, 2011 Dec 05, 2017 Patent
Anti-il-6/il-6r antibodies Jan 12, 2016 Nov 28, 2017 Patent
Readily isolated bispecific antibodies with native immunoglobulin format Mar 13, 2013 Nov 14, 2017 Patent
See all 57 patents